Literature DB >> 15122239

Finally, mice with CF lung disease.

Raymond A Frizzell, Joseph M Pilewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15122239     DOI： 10.1038/nm0504-452

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.

Authors:  Timothy E Corcoran; Joseph E Godovchik; Karl H Donn; David R Busick; Jennifer Goralski; Landon W Locke; Matthew R Markovetz; Michael M Myerburg; Ashok Muthukrishnan; Lawrence Weber; Ryan T Lacy; Joseph M Pilewski
Journal:  Pediatr Pulmonol       Date:  2017-07-24

2.  CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation.

Authors:  Veronica Marcos; Zhe Zhou; Ali Onder Yildirim; Alexander Bohla; Andreas Hector; Ljubomir Vitkov; Eva-Maria Wiedenbauer; Wolf Dietrich Krautgartner; Walter Stoiber; Bernd H Belohradsky; Nikolaus Rieber; Michael Kormann; Barbara Koller; Adelbert Roscher; Dirk Roos; Matthias Griese; Oliver Eickelberg; Gerd Döring; Marcus A Mall; Dominik Hartl
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

3.  The CFTR and ENaC debate: how important is ENaC in CF lung disease?

Authors:  James F Collawn; Ahmed Lazrak; Zsuzsa Bebok; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-04-06       Impact factor: 5.464

4.  Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.

Authors:  Alessandro Luciani; Valeria Rachela Villella; Speranza Esposito; Nicola Brunetti-Pierri; Diego Medina; Carmine Settembre; Manuela Gavina; Laura Pulze; Ida Giardino; Massimo Pettoello-Mantovani; Maria D'Apolito; Stefano Guido; Eliezer Masliah; Brian Spencer; Sonia Quaratino; Valeria Raia; Andrea Ballabio; Luigi Maiuri
Journal:  Nat Cell Biol       Date:  2010-08-15       Impact factor: 28.824

5.  Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway.

Authors:  T E Corcoran; K M Thomas; M M Myerburg; A Muthukrishnan; L Weber; R Frizzell; J M Pilewski
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

6.  Liquid hyper-absorption as a cause of increased DTPA clearance in the cystic fibrosis airway.

Authors:  Timothy E Corcoran; Kristina M Thomas; Stefanie Brown; Michael M Myerburg; Landon W Locke; Joseph M Pilewski
Journal:  EJNMMI Res       Date:  2013-02-27       Impact factor: 3.138
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.